年龄相关性黄斑变性单核苷酸多态性与假性玻璃膜疣的关联:AMD治疗对比试验数据的二次分析
该研究对835名参加AMD治疗对比试验的美国新生血管性AMD患者进行基因分型,分析CFH、ARMS2、HTRA1等基因单核苷酸多态性与假性玻璃膜疣及其亚型的关联。在755名可评估者中,28.2%存在假性玻璃膜疣;校正年龄、性别和吸烟后,ARMS2风险等位基因T(TT vs GG)和HTRA1(AA vs GG)与假性玻璃膜疣风险升高相关,CFH Y402H风险等位基因C(CC vs TT)与风险降低相关但多重比较校正后未达统计学显著。CFH Y402H、ARMS2、HTRA1和C3与网状假性玻璃膜疣显著相关。
要点
- 755名新生血管性AMD患者中213名(28.2%)存在假性玻璃膜疣。
- 校正混杂后ARMS2 TT vs GG的OR为1.93(95%CI 1.19-3.12,P=0.04)。
- HTRA1 AA vs GG的OR为2.04(95%CI 1.26-3.31,P=0.03)。
核心结论
- 在新生血管性AMD患者中,AMD风险等位基因ARMS2和HTRA1与假性玻璃膜疣风险升高相关,CFH Y402H风险等位基因与假性玻璃膜疣风险降低相关,支持既往研究结果。
- 作者认为理解这些单核苷酸多态性在假性玻璃膜疣发生中的作用可能有助于加深对AMD发病机制的理解并帮助开发未来疗法。
研究设计与样本
- 研究设计为对AMD治疗对比试验美国参与者横断面数据的事后分析。
- 对835名参与者采用TaqMan方法检测rs1061170(CFH Y402H)、rs800292(CFH I62V)、rs10490924(ARMS2 A69S)、rs11200638(HTRA1)、rs547154(C2)、rs2230199(C3 R102G)、rs10468017(LIPC)和rs4151667(CFB L9H)位点。
- 835名入组基因分型者中755名(90.4%)接受假性玻璃膜疣评估,其中471名(62.4%)为女性、750名(99.3%)为白人,平均(SD)年龄78.3(7.5)岁。
主要发现
- 755名参与者中213名(28.2%)存在假性玻璃膜疣,其中点状107名(14.2%)、网状180名(23.8%)、融合状102名(13.5%)。
- 校正年龄、性别和吸烟状态后,ARMS2风险等位基因T与假性玻璃膜疣风险升高相关(TT vs GG:OR 1.93,95%CI 1.19-3.12,P=0.04)。
- HTRA1存在类似关联(AA vs GG:OR 2.04,95%CI 1.26-3.31,P=0.03)。
- CFH Y402H风险等位基因C与假性玻璃膜疣风险降低相关(CC vs TT:OR 0.61,95%CI 0.38-0.97),但多重比较校正后未达统计学显著(P=0.20)。
- CFH Y402H、ARMS2、HTRA1和C3与网状假性玻璃膜疣显著相关。
关键数值与推荐
- 假性玻璃膜疣及其亚型(点状、网状、融合状)由彩色眼底照相、无赤光图像和荧光素血管造影确定。
- 关联分析校正年龄、性别和吸烟状态,多重比较校正采用原文报告的方法(原文未写明具体校正方法)。
- ARMS2 TT vs GG的OR为1.93(95%CI 1.19-3.12,P=0.04),HTRA1 AA vs GG的OR为2.04(95%CI 1.26-3.31,P=0.03)。
- CFH Y402H CC vs TT的OR为0.61(95%CI 0.38-0.97),多重比较校正后P=0.20。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Previous studies investigating the association of single-nucleotide polymorphisms (SNPs) that confer increased risk of age-related macular degeneration (AMD) with pseudodrusen have yielded conflicting results and have not evaluated other AMD SNPs or pseudodrusen subtypes. OBJECTIVE: To determine the association of SNPs in the complement factor H (CFH), age-related maculopathy susceptibility 2 (ARMS2), HtrA serine peptidase 1 (HTRA1), complement C2 (C2), complement C3 (C3), lipase C (LIPC), and complement factor B (CFB) genes with the presence of pseudodrusen and pseudodrusen subtypes (ie, dot, reticular, and confluent). DESIGN, SETTING, AND PARTICIPANTS: In this post hoc analysis of cross-sectional data from US participants in the Comparison of AMD Treatments Trials, genotyping was performed in 835 participants with TaqMan assays for the SNPs rs1061170 (Y402H variant in CFH), rs800292 (I62V variant in CFH), rs10490924 (A69S variant in ARMS2), rs11200638 (HTRA1), rs547154 (C2), rs2230199 (R102G variant in C3), rs10468017 (LIPC), and rs4151667 (L9H variant in CFB). MAIN OUTCOMES AND MEASURES: Presence and subtype of baseline pseudodrusen in either eye determined using color fundus photography, red-free images, and fluorescein angiograms. RESULTS: Among 835 participants enrolled for genotyping, 755 (90.4%) were evaluated for pseudodrusen. Of these, 471 (62.4%) were female and 750 (99.3%) were white, and the mean (SD) age was 78.3 (7.5) years. A total of 213 of 755 participants (28.2%) had pseudodrusen (107 [14.2%] had dot pseudodrusen, 180 [23.8%] had reticular pseudodrusen, and 102 [13.5%] had confluent pseudodrusen). After adjusting for age, sex, and smoking status, the ARMS2 risk allele T was associated with higher risk of pseudodrusen (odds ratio [OR], 1.93; 95% CI, 1.19-3.12) for TT vs GG (P = .04). A similar association was found for HTRA1 (OR, 2.04; 95% CI, 1.26-3.31) for AA vs GG (P = .03). The CFH Y402H risk allele C was associated with lower risk of pseudodrusen (OR, 0.61; 95% CI, 0.38-0.97) for CC vs TT but was not statistically significant after correcting for multiple comparison (P = .20). CFH Y402H, ARMS2, HTRA1, and C3 were significantly associated with reticular pseudodrusen. CONCLUSIONS AND RELEVANCE: Among patients with neovascular AMD, the AMD risk alleles ARMS2 and HTRA1 were associated with an increased risk of pseudodrusen and the risk allele CFH Y402H was associated with lower risk of pseudodrusen, supporting findings from previous studies. Understanding the role of these SNPs in the development of pseudodrusen might improve our understanding of the pathogenesis of AMD and help develop future therapies.
引用
- Lin LY, Zhou Q, Hagstrom S, et al. Association of Single-Nucleotide Polymorphisms in Age-Related Macular Degeneration With Pseudodrusen: Secondary Analysis of Data From the Comparison of AMD Treatments Trials. JAMA Ophthalmol. 2018. PMID: 29801032. doi:10.1001/jamaophthalmol.2018.1231
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。